Patent · US Active

Covalent multi-specific antibody

US12134661B1 · kind B1 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2024
Grant dateNov 5, 2024
Priority date
Expiry dateMay 17, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are novel bispecific and tri-specific antibodies with increased stability and use thereof for therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.